Literature DB >> 1347311

Effects of in vivo T lymphocyte subset depletion on mycobacterial infections in mice.

C M Flory1, R D Hubbard, F M Collins.   

Abstract

The relative importance of CD4+ and CD8+ T cell subsets in the expression of acquired resistance to systemic infection by Mycobacterium kansasii was determined. T cell subsets were depleted in thymectomized C57BL/6 mice by the intravenous administration of monoclonal antibodies directed against the relevant T cell determinants. Depletion of the CD4+ subset exacerbated the severity of the infection in intravenously challenged mice. This effect was apparent in the first 2 weeks of the infection and persisted throughout the 12 weeks of the study. On the other hand, depletion of the CD8+ cells had no apparent effect on the growth curves. Infections by Mycobacterium tuberculosis Erdman or bacille Calmette-Guérin (BCG) Pasteur were also substantially enhanced by CD4 depletion, but not by the depletion of CD8+ cells. The effect of subset depletion on infections by M. tuberculosis and BCG was examined in both innately susceptible C57BL/6 mice and innately resistant B6D2 mice.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347311     DOI: 10.1002/jlb.51.3.225

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  23 in total

Review 1.  Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis Infection.

Authors:  Katrin D Mayer-Barber; Daniel L Barber
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-17       Impact factor: 6.915

Review 2.  Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus.

Authors:  Samuel M Behar; Stephen M Carpenter; Matthew G Booty; Daniel L Barber; Pushpa Jayaraman
Journal:  Semin Immunol       Date:  2014-10-11       Impact factor: 11.130

Review 3.  Latent tuberculosis infection: myths, models, and molecular mechanisms.

Authors:  Noton K Dutta; Petros C Karakousis
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

4.  CD4+ T cells contain early extrapulmonary tuberculosis (TB) dissemination and rapid TB progression and sustain multieffector functions of CD8+ T and CD3- lymphocytes: mechanisms of CD4+ T cell immunity.

Authors:  Shuyu Yao; Dan Huang; Crystal Y Chen; Lisa Halliday; Richard C Wang; Zheng W Chen
Journal:  J Immunol       Date:  2014-01-31       Impact factor: 5.422

5.  Suboptimal Antigen Presentation Contributes to Virulence of Mycobacterium tuberculosis In Vivo.

Authors:  Patricia S Grace; Joel D Ernst
Journal:  J Immunol       Date:  2015-11-16       Impact factor: 5.422

6.  Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles.

Authors:  Andreia P Soares; Thomas J Scriba; Sarah Joseph; Ryhor Harbacheuski; Rose Ann Murray; Sebastian J Gelderbloem; Anthony Hawkridge; Gregory D Hussey; Holden Maecker; Gilla Kaplan; Willem A Hanekom
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

7.  Inflammatory response following intranasal infection with Mycobacterium avium complex: role of T-cell subsets and gamma interferon.

Authors:  B M Saunders; C Cheers
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

8.  Increased gamma-delta T-lymphocyte response to Mycobacterium bovis BCG in major histocompatibility complex class I-deficient mice.

Authors:  D Muller; P Pakpreo; J Filla; K Pederson; F Cigel; V Malkovska
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

9.  Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; M M Goldstein; K J Triebold; B Koller; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

Review 10.  Defining features of protective CD4 T cell responses to Mycobacterium tuberculosis.

Authors:  Shunsuke Sakai; Katrin D Mayer-Barber; Daniel L Barber
Journal:  Curr Opin Immunol       Date:  2014-08       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.